betadine
actiofarma, uab - povidonas, joduotas - tepalas - 100 mg/g - povidone-iodine
betadine
lex ano, uab - povidonas, joduotas - tepalas - 200 mg; 100 mg/g - povidone-iodine
betadine
tojaris projektai, uab - povidonas, joduotas - odos tirpalas - 100 mg/ml; 100 mg - povidone-iodine
betadine
lex ano, uab - povidonas, joduotas - odos tirpalas - 100 mg/ml - povidone-iodine
betadine
limedika, uab - povidonas, joduotas - tepalas - 100 mg/g; 100 mg/ml - povidone-iodine
5-nok
sandoz d.d. - nitroksolinas - dengtos tabletės - 50 mg - nitroxoline
thromboreductin
aop orphan pharmaceuticals gmbh - anagrelidas - kietosios kapsulės - 0,5 mg - anagrelide
tri-regol
gedeon richter plc - levonorgestrelis/etinilestradiolis+levonorgestrelis/etinilestradiolis+levonorgestrelis/etinilestradiolis - dengtos tabletės - 50 µg/30 µg + 75 µg/40 µg + 125 µg/30 µg - levonorgestrel and ethinylestradiol
remolexam
vital pharma gmbh - meloksikamas - injekcinis tirpalas - 7,5 mg; 15 mg/1,5 ml - meloxicam
sapropterin dipharma
dipharma arzneimittel gmbh - sapropterin dihidrochloridas - phenylketonurias - kiti virškinimo trakto ir metabolizmo produktus, - sapropterin dipharma is indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with phenylketonuria (pku) who have been shown to be responsive to such treatment. sapropterin dipharma is also indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with tetrahydrobiopterin (bh4) deficiency who have been shown to be responsive to such treatment.